Materials 2013, 6(3), 817-840; doi:10.3390/ma6030817
Review

Dye Sensitizers for Photodynamic Therapy

Received: 31 January 2013; in revised form: 20 February 2013 / Accepted: 22 February 2013 / Published: 6 March 2013
(This article belongs to the Special Issue Advances in Colorants)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Photofrin® was first approved in the 1990s as a sensitizer for use in treating cancer via photodynamic therapy (PDT). Since then a wide variety of dye sensitizers have been developed and a few have been approved for PDT treatment of skin and organ cancers and skin diseases such as acne vulgaris. Porphyrinoid derivatives and precursors have been the most successful in producing requisite singlet oxygen, with Photofrin® still remaining the most efficient sensitizer (quantum yield = 0.89) and having broad food and drug administration (FDA) approval for treatment of multiple cancer types. Other porphyrinoid compounds that have received approval from US FDA and regulatory authorities in other countries include benzoporphyrin derivative monoacid ring A (BPD-MA), meta-tetra(hydroxyphenyl)chlorin (m-THPC), N-aspartyl chlorin e6 (NPe6), and precursors to endogenous protoporphyrin IX (PpIX): 1,5-aminolevulinic acid (ALA), methyl aminolevulinate (MAL), hexaminolevulinate (HAL). Although no non-porphyrin sensitizer has been approved for PDT applications, a small number of anthraquinone, phenothiazine, xanthene, cyanine, and curcuminoid sensitizers are under consideration and some are being evaluated in clinical trials. This review focuses on the nature of PDT, dye sensitizers that have been approved for use in PDT, and compounds that have entered or completed clinical trials as PDT sensitizers.
Keywords: photodynamic therapy; photosensitizers; porphyrins; clinical trials; target organs
PDF Full-text Download PDF Full-Text [304 KB, uploaded 6 March 2013 08:51 CET]

Export to BibTeX |
EndNote


MDPI and ACS Style

Ormond, A.B.; Freeman, H.S. Dye Sensitizers for Photodynamic Therapy. Materials 2013, 6, 817-840.

AMA Style

Ormond AB, Freeman HS. Dye Sensitizers for Photodynamic Therapy. Materials. 2013; 6(3):817-840.

Chicago/Turabian Style

Ormond, Alexandra B.; Freeman, Harold S. 2013. "Dye Sensitizers for Photodynamic Therapy." Materials 6, no. 3: 817-840.

Materials EISSN 1996-1944 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert